Iridex (IRIX) Acquisitions (2011 - 2022)

Iridex (IRIX) posted quarterly Acquisitions of -$5.3 million for Q4 2022, down 200.0% quarter-over-quarter from $5.3 million in Q2 2021.

Iridex (IRIX) Acquisitions (2011 - 2022) Analysis & Trends

Iridex's Acquisitions history runs 3 years deep, the most recent figure standing at -$5.3 million for Q4 2022.

In Q4 2022, Acquisitions changed N/A year-over-year to -$5.3 million; the TTM figure through Oct 2021 stood at $5.3 million (changed N/A YoY), while the FY2022 annual figure was $5.3 million, changed N/A from the prior year.
Acquisitions for Q4 2022 stood at -$5.3 million, down from $5.3 million in the prior quarter.
The five-year high for Acquisitions was $5.3 million in Q2 2021, with the low at -$5.3 million in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	-
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	437.00 Mn
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	406.00 Mn
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	-
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	-4.00 Mn
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	-3.49 Mn
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	16.00 Mn
10	Iridex	13.00 Mn	8.32 Mn	4.30 Mn	-

Download Data